Natural product-derived therapy for Human Leukemias: Myrtenol, isolated from Cardamom, suppresses B-Cell and myeloid leukemias via up regulation of the tumor suppressor IRF4, 15/May/2017, 9. 24 am

Anti-telomerase cancer therapy: MiR-2861 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and the cellular immortality gene telomerase and inhibits cancer progression via down-regulation of it target gene, 15/May/2017, 9.23 am
May 15, 2017
Natural product-derived therapy for Acute Myeloid Leukemia: Dihydromyricetin, one of the main components found in cedrus deodara, decreases the expression of BCLAF1, promotes differentiation of acute myeloid leukemic cells, restores treatment responsiveness, increases therapeutic index of anticancer drugs, and promotes regression of AML via up-regulation of its target gene, 15/May/2017, 9.25 am
May 15, 2017
Show all

Introduction: What they say

Noble laureate in Physiology/Medicine (1975) Prof. David Baltimore, from California Institute of Technology, California, USA, had reported in the July 8, 2014 issue of the Journal “Blood” that: “Dual mechanisms by which MiR-125b represses IRF4 to induce myeloid/B-cell leukemias.” 


What we say:

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-derived therapy for Human Leukemias: Myrtenol, isolated from Cardamom,  suppresses B-Cell and myeloid leukemias via up regulation of the tumor suppressor IRF4


From Research findings to Therapeutic opportunity:

This study suggests that Myrtenol, by increasing the expression of  its target gene, it may increase the expression of a number of tumor suppressor genes, including IRF4. Thereby, it could inhibit the progression of B-Cell and myeloid leukemias (fig. 1).

price-100

[easy_payment currency=”USD”]

Taken together, this study suggests that pharmacological formulations encompassing       “Myrtenol  or its analogues, either alone or in combination with other anticancer drugs”, may be used to inhibit B-Cell and myeloid leukemias.

Figure 1 Mechanistic insight into how Myrtenol increases the expression of IRF4 to prevent cancer proliferation


Details of the research details

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How Myrtenol increases the expression of IRF4?

Amount: $ 100

For purchase and payment details, you may reach us at admin@genomediscovery.org

# Research cooperation


References:

Web: http://genomediscovery.org or newbioideas.com/

CitationBoominathan, L., Natural product-derived therapy for Human Leukemias: Myrtenol, isolated from Cardamom,  suppresses B-Cell and myeloid leukemias via up regulation of the tumor suppressor IRF4, 15/May/2017, 9. 24 am,  Genome-2-Bio-Medicine Discovery Center.

Courtesy: When you cite drop us a line at admin@genomediscovery.org

Comments are closed.